These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2425725)

  • 1. Augmented antibody response to live attenuated measles vaccine in children with Plasmodium falciparum parasitaemia.
    Smedman L; Silva MC; Gunnlaugsson G; Norrby E; Zetterstrom R
    Ann Trop Paediatr; 1986 Jun; 6(2):149-53. PubMed ID: 2425725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up of the antibody response to measles vaccine in a rural area of Guinea-Bissau.
    Smedman L; Gunnlaugsson G; Norrby E; Silva MC; Zetterström R
    Acta Paediatr Scand; 1988 Nov; 77(6):885-9. PubMed ID: 3144827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised trial of effect of vitamin A supplementation on antibody response to measles vaccine in Guinea-Bissau, west Africa.
    Benn CS; Aaby P; Balé C; Olsen J; Michaelsen KF; George E; Whittle H
    Lancet; 1997 Jul; 350(9071):101-5. PubMed ID: 9228962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chloroquine treatment of malaria does not increase antibody response to measles vaccination. A controlled study of 580 rural children living in an endemic malaria area.
    Cénac A; Develoux M; Djibo A
    Trans R Soc Trop Med Hyg; 1988; 82(3):405. PubMed ID: 3068857
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials of Edmonston-Zagreb measles vaccine in Guinea-Bissau: serological responses following vaccination with Edmonston-Zagreb strain at 4-8 months versus vaccination with Schwarz strain at 9-12 months of age.
    Jensen TG; Whittle H; Mordhorst CH; Pedersen IR; Thaarup J; Poulsen A; Sodemann M; Jakobsen M; Brink L; Gansted U
    Vaccine; 1994 Aug; 12(11):1026-31. PubMed ID: 7975843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles in Tanzania: antibody response in children after vaccination and antibody state of mothers and newborns.
    de Haas PW; Masurel N; Anker WJ
    Trans R Soc Trop Med Hyg; 1983; 77(2):267-70. PubMed ID: 6868109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles antibody responses after early two dose trials in Guinea-Bissau with Edmonston-Zagreb and Schwarz standard-titre measles vaccine: better antibody increase from booster dose of the Edmonston-Zagreb vaccine.
    Garly ML; Balé C; Martins CL; Monteiro M; George E; Kidd M; Dias F; Aaby P; Whittle HC
    Vaccine; 2001 Feb; 19(15-16):1951-9. PubMed ID: 11228365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intermittent preventive treatment for malaria during infancy on serological responses to measles and other vaccines used in the Expanded Programme on Immunization: results from five randomised controlled trials.
    Crawley J; Sismanidis C; Goodman T; Milligan P;
    Lancet; 2012 Sep; 380(9846):1001-10. PubMed ID: 22850358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children].
    Unalan H; Ustaçelebi S
    Mikrobiyol Bul; 1985 Oct; 19(4):218-28. PubMed ID: 3831724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles vaccine coverage and immune response in children of Caiabi and Metuktire Indian tribes living in malarial endemic area: Parque indígena do Xingu, Central Brazil.
    Spindel R; Baruzzi RG; Souza VA; Ferreira AW; Avila SL
    Trop Doct; 2001 Jul; 31(3):142-4. PubMed ID: 11444333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine].
    Zhonghua Yi Xue Za Zhi; 1989 Jul; 69(7):389-91. PubMed ID: 2598095
    [No Abstract]   [Full Text] [Related]  

  • 14. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus.
    Christenson B; Böttiger M
    Biologicals; 1990 Jul; 18(3):207-11. PubMed ID: 2257133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term antibody response after measles vaccination in an isolated arctic society in Greenland.
    Pedersen IR; Mordhorst CH; Ewald T; von Magnus H
    Vaccine; 1986 Sep; 4(3):173-8. PubMed ID: 3532604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 18. Measles antibodies and response to vaccination in children aged less than 14 months: implications for age of vaccination.
    Borràs E; Urbiztondo L; Costa J; Batalla J; Torner N; Plasencia A; Salleras L; Domínguez À;
    Epidemiol Infect; 2012 Sep; 140(9):1599-606. PubMed ID: 22074684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of measles virus response with reference to vaccine viability, age, protein energy malnutrition and malaria in the tropics.
    Kimati VP; Loretu K; Munube GM; Kimboi F
    J Trop Pediatr; 1981 Aug; 27(4):205-9. PubMed ID: 6793733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.